Physician profile
David J Levine
NPI 1134123029
$676.69
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $18.48 · 2021: $51.54 · 2022: $97.23 · 2023: $234 · 2024: $90.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $240.89 | 2020-2023 | Krystexxa |
| Nevro Corp. | $127.77 | 2023 | Senza |
| Amgen INC. | $90.25 | 2024 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $86.44 | 2019 | |
| Ossio INC | $32.66 | 2021 | |
| Kci USA, INC. | $20.88 | 2019 | |
| Wright Medical Technology, INC. | $17.19 | 2019 | |
| Smith+Nephew, INC. | $17.12 | 2019 | |
| Bioventus LLC | $17.08 | 2019 | |
| Melinta Therapeutics, LLC | $13.95 | 2019 | |
| Merck Sharp & Dohme LLC | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.